Industries > Pharma > Antibiotics Market Report 2021-2031
Antibiotics Market Report 2021-2031
Forecasts by Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-AC, Others), by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Gender (Male, Female), by Age (0-14 Years, 15-54 Years, 55 Years and Above), by Route of Administration (Oral, Intravenous, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Antibiotics Companies AND COVID-19 Recovery Scenarios
Ageing Population to Offer Lucrative Growth Prospects for Antibiotics Market Players
Adults over the age of 65 are widely regarded as one of the most vulnerable segments of the population. The world is approaching a demographic tipping point. Since the dawn of humanity, young children have outnumbered their parents. Within five years, however, the number of people aged 65 and up would outnumber children under the age of five. Because of falling fertility rates and substantial rises in life expectancy, population ageing would continue, if not intensify. According to the World Health Organization, the number of people aged 65 and up is expected to rise from 524 million in 2010 to nearly 1.5 billion in 2050, with the majority of the increase occurring in developing countries.
Growing Burden of Infectious Diseases to Fuel Antibiotics Market Growth
The growing burden of bacterial infections is projected to fuel the antibiotics market over the forecast period. The rising prevalence of tuberculosis, malaria, pneumonia, bacterial skin infections, HIV/AIDS, urinary tract infections (UTI), and other diseases will support the market’s healthy growth over the forecast period from 2021 to 2031.
UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.
To access the data contained in this document please email contactus@visiongain.com
Which Factors are Fueling Antibiotics Industry Growth?
• Growing Burden of Infectious Diseases to Fuel Market Growth
• Rising Ageing Population Patient Pool to Drive Growth
• Adoption of Digital Health Technology to Boost Antibiotics Market Growth
Which Factors are Restraining Growth?
• Strict Regulatory Scenarios to Hamper Market Growth
• Rising Antibiotic Resistance to Restrain Market Growth
How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. The report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks.
Discover how to stay ahead
Our 640+ pages report provides 900+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibiotics Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Drug Class
• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolide
• Carbapenem
• Aminoglycoside
• Sulfonamide
• 7-ACA
• Others
Action Mechanism
• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others
Gender
• Male
• Female
Age
• 0-14 years
• 15-54 years
• 55 years and above
Route of Administration
• Oral
• Intravenous
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 26 national markets:
By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Denmark
• Norway
• Sweden
• Finland
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• Singapore
• Malaysia
• Sri Lanka
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America
• Middle East and Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for Antibiotics Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which regions hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Prospects for established firms and those seeking to enter the market
Including company profiles for 16 of the major companies involved in the antibiotics market. Some of the companies profiled in this report include Abbott Laboratories, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Viatris (Mylan), Novartis International AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Cipla Ltd., Allergan (AbbVie Inc.), Cumberland Pharmaceuticals, Inc., LUPIN, Melinta Therapeutics LLC, Amneal Pharmaceuticals LLC, and WOCKHARDT.
Key Questions Answered by this Report:
• What is the current size of the overall global antibiotics market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall antibiotics market over the next ten years?
• What are the main segments within the overall antibiotics market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world antibiotics? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2031?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Which are the leading companies and what are their activities, results, developments, and prospects?
• What are the main trends that will affect the world antibiotics market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities, and threats for the market?
• How will the global antibiotics market evolve over the forecasted period, 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is intended for everybody needing commercial analyses for the Global Antibiotics Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Antibiotics Market Report 2021-2031: Forecasts by Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-AC, Others), by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Gender (Male, Female), by Age (0-14 Years, 15-54 Years, 55 Years and Above), by Route of Administration (Oral, Intravenous, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Antibiotics Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Antibiotics Market
1.2 Antibiotics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Market Drivers
3.1.1 Growing Burden of Infectious Diseases to Fuel Market Growth
3.1.2 Adoption of Digital Health Technology to Boost Antibiotics Market Growth
3.1.3 Rising Ageing Population Patient Pool to Drive Growth
3.2 Market Restraints
3.2.1 Strict Regulatory Scenarios to Hamper Market Growth
3.2.2 Rising Antibiotic Resistance to Restrain Market Growth
3.3 Market Opportunities
3.4 SWOT Analysis
3.4.1 Strengths of Antibiotics Market
3.4.2 Weaknesses of Antibiotics Market
3.4.3 Opportunities in Antibiotics Market
3.4.4 Threats in Antibiotics Market
3.5 Industry analysis - Porter’s
3.5.1 Bargaining Power of Buyers (Low)
3.5.2 Bargaining Power of Suppliers (Low)
3.5.3 Intensity of Competitive Rivalry (High)
3.5.4 Threat of Substitute (Low)
3.5.5 Threat of New Entrants (Low)
3.6 Industry analysis – PEST Analysis
3.6.1 Political Factors Impacting Antibiotics Market
3.6.2 Economic Factors Impacting Antibiotics Market
3.6.3 Social Factors Impacting Antibiotics Market
3.6.4 Technological Factors Impacting Antibiotics Market
4 Global Antibiotics Market by Drug Class
4.1 Cephalosporin Segment Market Forecast, 2021-2031
4.1.1 Rising Prevalence of Infectious Diseases to Fuel Segmental Growth
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Penicillin Segment Market Forecast, 2021-2031
4.2.1 Penicillin Accounts for Majority of the Antibiotics Market Share
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 Fluoroquinolone Segment Market Forecast, 2021-2031
4.3.1 Fluoroquinolone Segment Anticipated to Witness Highest Growth Over the Forecast Period
4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.4 Macrolide Segment Market Forecast, 2021-2031
4.4.1 Rising Demand of Drugs for Bacterial Skin Infections to Fuel Growth
4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.5 Carbapenem Segment Market Forecast, 2021-2031
4.5.1 Market Overview
4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.6 Aminoglycoside Segment Market Forecast, 2021-2031
4.6.1 Market Overview
4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.7 Sulfonamide Segment Market Forecast, 2021-2031
4.7.1 Market Overview
4.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.8 7-ACA Segment Market Forecast, 2021-2031
4.8.1 Market Overview
4.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.9 Others Segment Market Forecast, 2021-2031
4.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Antibiotics Market by Action Mechanism
5.1 Cell Wall Synthesis Inhibitors Segment Market Forecast, 2021-2031
5.1.1 Cell Wall Synthesis Inhibitors Accounts for Majority of the Market Share
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Protein Synthesis Inhibitors Segment Market Forecast, 2021-2031
5.2.1 R&D Initiatives Projected to Boost Protein Synthesis Inhibitors Growth
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 DNA Synthesis Inhibitors Segment Market Forecast, 2021-2031
5.3.1 Market Overview
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 RNA Synthesis Inhibitors Segment Market Forecast, 2021-2031
5.4.1 RNA Synthesis Inhibitors Anticipated to Witness Fastest CAGR Through 2031
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.5 Mycolic Acid Inhibitors Segment Market Forecast, 2021-2031
5.5.1 Market Overview
5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.6 Others Segment Market Forecast, 2021-2031
5.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Antibiotics Market by Gender
6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Antibiotics Market by Age Group
7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 Antibiotics Market by Route of Administration
8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 North America Antibiotics Market
9.1 North America Dominates the Global Antibiotics Market
9.2 North America Antibiotics Market by Country, Forecast 2021-2031
9.3 North America Antibiotics Market by Action Mechanism, Forecast 2021-2031
9.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Action Mechanism Forecast, 2021-2031
9.4 North America Antibiotics Market by Drug Class, Forecast 2021-2031
9.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Drug Class Forecast, 2021-2031
9.5 North America Antibiotics Market by Gender, Forecast 2021-2031
9.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Gender Forecast, 2021-2031
9.6 North America Antibiotics Market by Age Group, Forecast 2021-2031
9.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Age Group Forecast, 2021-2031
9.7 North America Antibiotics Market by Route of Administration, Forecast 2021-2031
9.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Route of Administration Forecast, 2021-2031
9.8 U.S. Antibiotics Market, Forecast 2021-2031
9.8.1 U.S. Currently Dominates the North American Antibiotics Market
9.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Antibiotics Market Forecast, 2021-2031
9.9 Canada Antibiotics Market, Forecast 2021-2031
9.9.1 Canadian Antibiotics Market to Witness Highest Growth Rate Across North American Region
9.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Antibiotics Market Forecast, 2021-2031
10 Europe Antibiotics Market
10.1 Growing Health Awareness to Fuel European Antibiotics Market Through 2031
10.2 Consumption of Antibactetrials in Community Across European Countries by ATC Group
10.3 Consumption of Antibactetrials in Hospital Sector Across European Countries by ATC Group
10.4 DDDs Per 1000 Inhabitants Per Day
10.5 Market Authorization & Reimbursements in Norway
10.6 Top 10 Potential Companies Outside Nordic Region
10.7 Regulatory Scenario Across Europe
10.8 Europe Antibiotics Market by Country, Forecast 2021-2031
10.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Country Forecast, 2021-2031
10.9 Europe Antibiotics Market by Action Mechanism, Forecast 2021-2031
10.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Action Mechanism Forecast, 2021-2031
10.10 Europe Antibiotics Market by Drug Class, Forecast 2021-2031
10.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Drug Class Forecast, 2021-2031
10.11 Europe Antibiotics Market by Gender, Forecast 2021-2031
10.11.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Gender Forecast, 2021-2031
10.12 Europe Antibiotics Market by Age Group, Forecast 2021-2031
10.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Age Group Forecast, 2021-2031
10.13 Europe Antibiotics Market by Route of Administration, Forecast 2021-2031
10.13.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Route of Administration Forecast, 2021-2031
10.14 Germany Antibiotics Market, Forecast 2021-2031
10.14.1 German Antibiotics Market to Witness Highest Growth Rate by 2031
10.14.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Antibiotics Market Forecast, 2021-2031
10.15 UK Antibiotics Market, Forecast 2021-2031
10.15.1 Collaboration Among Healthcare Organizations to Fuel Regional Antibiotics Market Growth
10.15.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Antibiotics Market Forecast, 2021-2031
10.16 France Antibiotics Market, Forecast 2021-2031
10.16.1 Rising Incidence of Infectious Diseases to Augur French Antibiotics Market Growth
10.16.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Antibiotics Market Forecast, 2021-2031
10.17 Italy Antibiotics Market, Forecast 2021-2031
10.17.1 High Awareness Regarding Usage of Antibiotics is Anticipated to Boost Italian Antibiotics Market
10.17.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Antibiotics Market Forecast, 2021-2031
10.18 Spain Antibiotics Market, Forecast 2021-2031
10.18.1 Incidence of Influenza to Boost Regional Market Growth
10.18.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Antibiotics Market Forecast, 2021-2031
10.19 Russia Antibiotics Market, Forecast 2021-2031
10.19.1 Awareness Regarding Health Issues Anticipated to Boost Antibiotics Market Growth Through 2031
10.19.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Antibiotics Market Forecast, 2021-2031
10.20 Denmark Antibiotics Market, Forecast 2021-2031
10.20.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Denmark Antibiotics Market Forecast, 2021-2031
10.21 Norway Antibiotics Market, Forecast 2021-2031
10.21.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Norway Antibiotics Market Forecast, 2021-2031
10.22 Sweden Antibiotics Market, Forecast 2021-2031
10.22.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Sweden Antibiotics Market Forecast, 2021-2031
10.23 Finland Antibiotics Market, Forecast 2021-2031
10.23.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Finland Antibiotics Market Forecast, 2021-2031
10.24 Netherlands Antibiotics Market, Forecast 2021-2031
10.24.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Netherlands Antibiotics Market Forecast, 2021-2031
10.25 Rest of Europe Antibiotics Market, Forecast 2021-2031
10.26 Market Revenue, 2021-2031
10.26.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Antibiotics Market Forecast, 2021-2031
11 Asia Pacific Antibiotics Market
11.1 Asia Pacific Antibiotics Market to Witness Highest Growth Rate Through 2031
11.2 Asia Pacific Antibiotics Market by Country, Forecast 2021-2031
11.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Country Forecast, 2021-2031
11.3 Asia Pacific Antibiotics Market by Action Mechanism, Forecast 2021-2031
11.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Action Mechanism Forecast, 2021-2031
11.4 Asia Pacific Antibiotics Market by Drug Class, Forecast 2021-2031
11.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Drug Class Forecast, 2021-2031
11.5 Asia Pacific Antibiotics Market by Gender, Forecast 2021-2031
11.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Gender Forecast, 2021-2031
11.6 Asia Pacific Antibiotics Market by Age Group, Forecast 2021-2031
11.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Age Group Forecast, 2021-2031
11.7 Asia Pacific Antibiotics Market by Route of Administration, Forecast 2021-2031
11.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Route of Administration Forecast, 2021-2031
11.8 China Antibiotics Market, Forecast 2021-2031
11.8.1 China Currently Dominating the APAC Antibiotics Market
11.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Antibiotics Market Forecast, 2021-2031
11.9 Japan Antibiotics Market, Forecast 2021-2031
11.9.1 Growing Burden of Infectious Diseases to Fuel Japanese Antibiotics Market
11.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Antibiotics Market Forecast, 2021-2031
11.10 India Antibiotics Market, Forecast 2021-2031
11.10.1 Indian Antibiotics Market to Witness Highest Growth Rate Through 2031
11.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Antibiotics Market Forecast, 2021-2031
11.11 Australia Antibiotics Market, Forecast 2021-2031
11.11.1 Australian Antibiotics Market to Offer Significant Growth Opportunities
11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Antibiotics Market Forecast, 2021-2031
11.12 Singapore Antibiotics Market, Forecast 2021-2031
11.12.1 Singapore Antibiotics Market to Grow on Account of Rising Incidence of Infectious Diseases
11.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Singapore Antibiotics Market Forecast, 2021-2031
11.13 Malaysia Antibiotics Market, Forecast 2021-2031
11.13.1 Growing Healthcare Infrastructure to Augur Antibiotics Market Growth
11.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Malaysia Antibiotics Market Forecast, 2021-2031
11.14 Sri Lanka Antibiotics Market, Forecast 2021-2031
11.14.1 Sri Lankan Antibiotics Market to Witness Significant Growth Through 2031
11.14.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Sri Lanka Antibiotics Market Forecast, 2021-2031
11.15 Rest of Asia Pacific Antibiotics Market, Forecast 2021-2031
11.15.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031
12 Latin America Antibiotics Market
12.1 Rising Healthcare Expenditure to Fuel Latin American Antibiotics Market Growth Through 2031
12.2 Latin America Antibiotics Market by Country, Forecast 2021-2031
12.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Country Forecast, 2021-2031
12.3 Latin America Antibiotics Market by Action Mechanism, Forecast 2021-2031
12.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Action Mechanism Forecast, 2021-2031
12.4 Latin America Antibiotics Market by Drug Class, Forecast 2021-2031
12.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Drug Class Forecast, 2021-2031
12.5 Latin America Antibiotics Market by Gender, Forecast 2021-2031
12.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Gender Forecast, 2021-2031
12.6 Latin America Antibiotics Market by Age Group, Forecast 2021-2031
12.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Age Group Forecast, 2021-2031
12.7 Latin America Antibiotics Market by Route of Administration, Forecast 2021-2031
12.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Route of Administration Forecast, 2021-2031
12.8 Brazil Antibiotics Market, Forecast 2021-2031
12.8.1 Brazil Currently Dominates the Latin American Antibiotics Market
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Antibiotics Market Forecast, 2021-2031
12.9 Mexico Antibiotics Market, Forecast 2021-2031
12.9.1 Mexico to Witness Highest Growth Rate Through 2031
12.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Antibiotics Market Forecast, 2021-2031
12.10 Argentina Antibiotics Market, Forecast 2021-2031
12.10.1 Argentina Antibiotics Market to Offer Significant Growth Prospects
12.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Argentina Antibiotics Market Forecast, 2021-2031
12.11 Colombia Antibiotics Market, Forecast 2021-2031
12.11.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Colombia Antibiotics Market Forecast, 2021-2031
12.12 Rest of Latin America Antibiotics Market, Forecast 2021-2031
12.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Antibiotics Market Forecast, 2021-2031
13 MEA Antibiotics Market
13.1 Growing Awareness to Boost Demand of Antibiotics Across MEA Region
13.2 MEA Antibiotics Market by Country, Forecast 2021-2031
13.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Country Forecast, 2021-2031
13.3 MEA Antibiotics Market by Action Mechanism, Forecast 2021-2031
13.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Action Mechanism Forecast, 2021-2031
13.4 MEA Antibiotics Market by Drug Class, Forecast 2021-2031
13.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Drug Class Forecast, 2021-2031
13.5 MEA Antibiotics Market by Gender, Forecast 2021-2031
13.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Gender Forecast, 2021-2031
13.6 MEA Antibiotics Market by Age Group, Forecast 2021-2031
13.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Age Group Forecast, 2021-2031
13.7 MEA Antibiotics Market by Route of Administration, Forecast 2021-2031
13.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Route of Administration Forecast, 2021-2031
13.8 GCC Antibiotics Market, Forecast 2021-2031
13.8.1 Lack of Awareness towards Antibiotics Usage to Restrain Market Growth Through 2031
13.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Antibiotics Market Forecast, 2021-2031
13.9 South Africa Antibiotics Market, Forecast 2021-2031
13.9.1 South Africa Antibiotics Market to Witness Highest Growth Rate Across MEA Region
13.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Antibiotics Market Forecast, 2021-2031
13.10 Rest of MEA Antibiotics Market, Forecast 2021-2031
13.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of MEA Antibiotics Market Forecast, 2021-2031
14 Company Profiles
14.1 Antibiotics Market: Company Wise Ranking
14.2 Key Strategies Followed by Leading Antibiotics Players
14.2.1 Internationalization
14.2.2 Product Range Breadth
14.2.3 Capability Development
14.2.4 Cost Differentiation
14.2.5 Vertical Integration
14.3 Abbott Laboratories
14.3.1 Company Snapshot
14.3.2 Abbott Laboratories Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.4 F. Hoffmann-La Roche Ltd.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 GlaxoSmithKline Plc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.6 Merck & Co. Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Viatris (Mylan)
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.8 Novartis International AG
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Product Benchmarking
14.8.5 Recent Developments
14.9 Pfizer Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.10 Sanofi
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.4 Product Benchmarking
14.10.5 Recent Developments
14.11 Teva Pharmaceutical Industries Ltd.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
14.11.5 Recent Developments
14.12 Cipla Ltd.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 Allergan (AbbVie Inc.)
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.4 Product Benchmarking
14.13.5 Recent Developments
14.14 Cumberland Pharmaceuticals, Inc
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.4 Product Benchmarking
14.14.5 Recent Developments
14.15 LUPIN
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.4 Product Benchmarking
14.15.5 Recent Developments
14.16 Melinta Therapeutics LLC
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Product Benchmarking
14.16.4 Recent Developments
14.17 Amneal Pharmaceuticals LLC
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Product Benchmarking
14.17.5 Recent Developments
14.18 WOCKHARDT
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.4 Product Benchmarking
14.18.5 Recent Developments
15 Conclusion
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Global Antibiotics Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 19 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 20 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 21 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 22 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 23 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 24 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 29 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 34 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 35 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 36 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 37 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 38 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 39 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 40 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 41 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 42 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 43 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 44 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 45 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 46 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 47 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 48 Global Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 49 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 55 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 60 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 61 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 62 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 63 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 64 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 65 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 66 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 67 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 68 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 69 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 70 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 71 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 72 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 73 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 74 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 75 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 76 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 77 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 78 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 79 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 80 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 85 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 86 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 87 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 88 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 89 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 90 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 91 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 92 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 93 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 94 North America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 95 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 96 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 97 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 98 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 99 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 100 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 101 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 102 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 103 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 104 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 105 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 106 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 107 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 108 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 109 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 110 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 111 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 112 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 113 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 114 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 115 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 116 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 117 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 118 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 119 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 120 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 121 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 122 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 123 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 124 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 125 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 126 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 127 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 128 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 129 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 130 Consumption of antibacterial for systemic use (ATC group J01) in the community, by country and ATC group level 3, EU/EEA, 2019 (expressed as DDD per 1 000 inhabitants per day)
Table 131 Consumption of antibacterials for systemic use (ATC group J01) in the Hospital Sector, by country and ATC group level 3, EU/EEA, 2019 (expressed as DDD per 1 000 inhabitants per day)
Table 132 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 133 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 138 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 143 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 148 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 153 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 154 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 155 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 156 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 157 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 158 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 159 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 160 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 161 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 162 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 163 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 164 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 165 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 166 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 167 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 168 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 169 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 170 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 171 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 172 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 173 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 174 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 175 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 176 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 177 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 178 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 179 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 180 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 181 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 182 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 183 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 184 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 185 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 186 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 187 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 188 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 189 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 190 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 191 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 192 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 193 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 194 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 195 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 196 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 197 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 198 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 199 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 200 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 201 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 202 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 203 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 208 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 213 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 218 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 223 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 224 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 225 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 226 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 227 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 228 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 229 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 230 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 231 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 232 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 233 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 234 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 235 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 236 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 237 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 238 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 239 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 240 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 241 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 242 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 243 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 244 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 245 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 246 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 247 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 248 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 249 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 250 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 251 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 252 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 253 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 254 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 255 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 256 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 257 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 258 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 259 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 260 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 261 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 262 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 263 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 264 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 265 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 266 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 267 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 268 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 269 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 270 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 271 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 272 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 273 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 274 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 275 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 276 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 277 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 278 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 279 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 280 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 281 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 282 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 283 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 284 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 285 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 286 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 287 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 288 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 289 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 290 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 291 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 292 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 293 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 294 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 295 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 296 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 297 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 298 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 299 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 300 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 301 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 302 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 303 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 304 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 305 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 306 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 307 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 308 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 309 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 310 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 311 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 312 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 313 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 314 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 315 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 316 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 317 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 318 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 319 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 320 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 321 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 322 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 323 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 324 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 325 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 326 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 327 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 328 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 329 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 330 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 331 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 332 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 333 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 334 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 335 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 336 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 337 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 338 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 339 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 340 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 341 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 342 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 343 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 344 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 345 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 346 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 347 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 348 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 349 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 350 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 351 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 352 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 353 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 354 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 355 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 356 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 357 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 358 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 359 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 360 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 361 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 362 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 363 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 364 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 365 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 366 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 367 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 368 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 369 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 370 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 371 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 372 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 373 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 374 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 375 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 376 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 377 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 378 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 379 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 380 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 381 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 382 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 383 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 384 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 385 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 386 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 387 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 388 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 389 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 390 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 391 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 392 Global Antibiotics Market: Company Ranking
Table 393 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 394 Abbott Laboratories: Product Benchmarking
Table 395 Abbott.: Recent Developments till 2021
Table 396 F.Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 397 F.Hoffmann-La Roche Ltd.: Product Benchmarking
Table 398 F.Hoffmann-La Roche Ltd.: Recent Developments till 2021
Table 399 GlaxoSmithKline Plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 400 GlaxoSmithKline Plc.: Product Benchmarking
Table 401 GlaxoSmithKline Plc.: Recent Developments till 2021
Table 402 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 403 Merck & Co. Inc.: Product Benchmarking
Table 404 Merck & Co. Inc.: Recent Developments till 2021
Table 405 Viatris: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 406 Viatris: Product Benchmarking
Table 407 Viatris: Recent Developments till 2021
Table 408 Novartis International AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 409 Novartis International AG: Product Benchmarking
Table 410 Novartis International AG: Recent Developments till 2021
Table 411 Pfizer Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 412 Pfizer Inc: Product Benchmarking
Table 413 Pfizer Inc: Recent Developments till 2021
Table 414 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 415 Sanofi: Product Benchmarking
Table 416 Sanofi.: Recent Developments till 2021
Table 417 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 418 Teva Pharmaceutical Industries Ltd: Product Benchmarking
Table 419 Teva Pharmaceutical Industries Ltd .: Recent Developments till 2021
Table 420 Cipla Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 421 Cipla Ltd: Product Benchmarking
Table 422 Cipla Ltd: Recent Developments till 2021
Table 423 Allergan (AbbVie Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 424 Allergan (AbbVie Inc.): Product Benchmarking
Table 425 Allergan (AbbVie Inc.): Recent Developments till 2021
Table 426 Cumberland Pharmaceuticals, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 427 Cumberland Pharmaceuticals, Inc: Product Benchmarking
Table 428 Cumberland Pharmaceuticals, Inc: Recent Developments, 2017-2019
Table 429 LUPIN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 430 LUPIN: Product Benchmarking
Table 431 LUPIN: Recent Developments till 2021
Table 432 Melinta Therapeutics LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 433 Melinta Therapeutics LLC: Product Benchmarking
Table 434 Melinta Therapeutics LLC: Recent Developments till 2021
Table 435 Amneal Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 436 Amneal Pharmaceuticals LLC: Product Benchmarking
Table 437 Amneal Pharmaceuticals LLC: Recent Developments, 2017-2019
Table 438 WOCKHARDT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 439 WOCKHARDT: Product Benchmarking
Table 440 WOCKHARDT: Recent Developments till 2021
List of Figures
Figure 1 Global Antibiotics Market Segmentation
Figure 2 Antibiotics Market: Market Trends
Figure 3 Antibiotics Market: SWOT Analysis
Figure 4 Porter’s Analysis
Figure 5 PEST Analysis
Figure 6 Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ million, AGR %)
Figure 7 Antibiotics Market Share Forecast by Drug Class, 2021, 2026, 2031 (%)
Figure 8 Antibiotics Market for Cephalosporin Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 9 Antibiotics Market for Cephalosporin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 10 Antibiotics Market for Cephalosporin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 11 Antibiotics Market for Cephalosporin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 12 Antibiotics Market for Cephalosporin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 13 Antibiotics Market for Penicillin Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 14 Antibiotics Market for Penicillin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 15 Antibiotics Market for Penicillin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 16 Antibiotics Market for Penicillin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 17 Antibiotics Market for Penicillin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 18 Antibiotics Market for Fluoroquinolone Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 19 Antibiotics Market for Fluoroquinolone Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 20 Antibiotics Market for Fluoroquinolone Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 21 Antibiotics Market for Fluoroquinolone Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 22 Antibiotics Market for Fluoroquinolone Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 23 Antibiotics Market for Macrolide Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 24 Antibiotics Market for Macrolide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 25 Antibiotics Market for Macrolide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 26 Antibiotics Market for Macrolide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 27 Antibiotics Market for Macrolide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 28 Antibiotics Market for Carbapenem Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 29 Antibiotics Market for Carbapenem Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 30 Antibiotics Market for Carbapenem Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 31 Antibiotics Market for Carbapenem Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 32 Antibiotics Market for Carbapenem Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 33 Antibiotics Market for Aminoglycoside Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 34 Antibiotics Market for Aminoglycoside Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 35 Antibiotics Market for Aminoglycoside Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 36 Antibiotics Market for Aminoglycoside Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 37 Antibiotics Market for Aminoglycoside Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 38 Antibiotics Market for Sulfonamide Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 39 Antibiotics Market for Sulfonamide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 40 Antibiotics Market for Sulfonamide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 41 Antibiotics Market for Sulfonamide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 42 Antibiotics Market for Sulfonamide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 43 Antibiotics Market for 7-ACA Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 44 Antibiotics Market for 7-ACA Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 45 Antibiotics Market for 7-ACA Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 46 Antibiotics Market for 7-ACA Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 47 Antibiotics Market for 7-ACA Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 48 Antibiotics Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 49 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 50 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 51 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 52 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 53 Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ million, AGR %)
Figure 54 Antibiotics Market Share Forecast by Action Mechanism, 2021, 2026, 2031 (%)
Figure 55 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 56 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 57 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 58 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 59 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 60 Antibiotics Market for Protein Synthesis Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 61 Antibiotics Market for Protein Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 62 Antibiotics Market for Protein Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 63 Antibiotics Market for Protein Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 64 Antibiotics Market for Protein Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 65 Antibiotics Market for DNA Synthesis Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 66 Antibiotics Market for DNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 67 Antibiotics Market for DNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 68 Antibiotics Market for DNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 69 Antibiotics Market for DNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 70 Antibiotics Market for RNA Synthesis Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 71 Antibiotics Market for RNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 72 Antibiotics Market for RNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 73 Antibiotics Market for RNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 74 Antibiotics Market for RNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 75 Antibiotics Market for Mycolic Acid Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 76 Antibiotics Market for Mycolic Acid Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 77 Antibiotics Market for Mycolic Acid Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 78 Antibiotics Market for Mycolic Acid Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 79 Antibiotics Market for Mycolic Acid Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 80 Antibiotics Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 81 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 Antibiotics Market Forecast by Gender, 2021-2031 (US$ million, AGR %)
Figure 86 Antibiotics Market by Gender Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 87 Antibiotics Market by Gender Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 88 Antibiotics Market by Gender Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 89 Antibiotics Market by Gender Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 90 Antibiotics Market Forecast by Age Group, 2021-2031 (US$ million, AGR %)
Figure 91 Antibiotics Market by Age Group Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 92 Antibiotics Market by Age Group Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 93 Antibiotics Market by Age Group Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 94 Antibiotics Market by Age Group Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 95 Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR %)
Figure 96 Antibiotics Market by Route of Administration Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 97 Antibiotics Market by Route of Administration Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 98 Antibiotics Market by Route of Administration Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 99 Antibiotics Market by Route of Administration Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 100 North America Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 101 North America Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 102 North America Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 103 North America Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 104 North America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 105 North America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 106 North America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 107 North America Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 108 North America Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 109 North America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 110 North America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 111 North America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 112 North America Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 113 North America Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 114 North America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 115 North America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 116 North America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 117 North America Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 118 North America Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 119 North America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 120 North America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 121 North America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 122 North America Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 123 North America Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 124 North America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 125 North America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 126 North America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 127 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 128 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 129 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 130 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 131 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 132 Canada Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 133 Canada Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 134 Canada Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 135 Canada Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 136 Canada Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 137 Consumption of antibacterials for systemic use (ATC group J01) in the community, by country and ATC group level 3, EU/EEA, 2019 (expressed as DDD per 1 000 inhabitants per day)
Figure 138 Europe Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 139 Europe Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 140 Europe Antibiotics Market by Country Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 141 Europe Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 142 Europe Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 143 Europe Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 144 Europe Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 145 Europe Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 146 Europe Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 147 Europe Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 148 Europe Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 149 Europe Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 150 Europe Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 151 Europe Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 152 Europe Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 153 Europe Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 154 Europe Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 155 Europe Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 156 Europe Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 157 Europe Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 158 Europe Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 159 Europe Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 160 Europe Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 161 Europe Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 162 Europe Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 163 Europe Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 164 Europe Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 165 Europe Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 166 Europe Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 167 Europe Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 168 Europe Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 169 Germany Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 170 Germany Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 171 Germany Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 172 Germany Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 173 Germany Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 174 UK Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 175 UK Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 176 UK Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 177 UK Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 178 UK Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 179 France Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 180 France Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 181 France Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 182 France Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 183 France Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 184 Italy Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 185 Italy Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 186 Italy Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 187 Italy Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 188 Italy Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 189 Spain Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 190 Spain Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 191 Spain Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 192 Spain Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 193 Spain Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 194 Russia Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 195 Russia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 196 Russia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 197 Russia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 198 Russia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 199 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 200 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 201 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 202 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 203 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 204 Norway Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 205 Norway Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 206 Norway Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 207 Norway Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 208 Norway Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 209 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 210 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 211 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 212 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 213 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 214 Finland Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 215 Finland Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 216 Finland Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 217 Finland Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 218 Finland Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 219 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 220 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 221 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 222 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 223 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 224 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 225 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 226 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 227 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 228 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 229 Asia Pacific Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 230 Asia Pacific Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 231 Asia Pacific Antibiotics Market by Country Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 232 Asia Pacific Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 233 Asia Pacific Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 234 Asia Pacific Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 235 Asia Pacific Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 236 Asia Pacific Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 237 Asia Pacific Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 238 Asia Pacific Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 239 Asia Pacific Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 240 Asia Pacific Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 241 Asia Pacific Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 242 Asia Pacific Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 243 Asia Pacific Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 244 Asia Pacific Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 245 Asia Pacific Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 246 Asia Pacific Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 247 Asia Pacific Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 248 Asia Pacific Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 249 Asia Pacific Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 250 Asia Pacific Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 251 Asia Pacific Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 252 Asia Pacific Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 253 Asia Pacific Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 254 Asia Pacific Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 255 Asia Pacific Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 256 Asia Pacific Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 257 Asia Pacific Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 258 Asia Pacific Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 259 Asia Pacific Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 260 China Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 261 China Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 262 China Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 263 China Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 264 China Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 265 Japan Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 266 Japan Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 267 Japan Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 268 Japan Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 269 Japan Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 270 India Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 271 India Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 272 India Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 273 India Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 274 India Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 275 Australia Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 276 Australia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 277 Australia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 278 Australia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 279 Australia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 280 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 281 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 282 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 283 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 284 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 285 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 286 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 287 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 288 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 289 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 290 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 291 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 292 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 293 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 294 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 295 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 296 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 297 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 298 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 299 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 300 Latin America Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 301 Latin America Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 302 Latin America Antibiotics Market by Country Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 303 Latin America Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 304 Latin America Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 305 Latin America Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 306 Latin America Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 307 Latin America Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 308 Latin America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 309 Latin America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 310 Latin America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 311 Latin America Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 312 Latin America Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 313 Latin America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 314 Latin America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 315 Latin America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 316 Latin America Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 317 Latin America Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 318 Latin America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 319 Latin America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 320 Latin America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 321 Latin America Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 322 Latin America Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 323 Latin America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 324 Latin America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 325 Latin America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 326 Latin America Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 327 Latin America Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 328 Latin America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 329 Latin America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 330 Latin America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 331 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 332 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 333 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 334 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 335 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 336 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 337 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 338 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 339 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 340 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 341 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 342 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 343 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 344 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 345 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 346 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 347 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 348 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 349 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 350 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 351 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 352 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 353 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 354 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 355 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 356 MEA Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 357 MEA Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 358 MEA Antibiotics Market by Country Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 359 MEA Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 360 MEA Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 361 MEA Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 362 MEA Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 363 MEA Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 364 MEA Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 365 MEA Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 366 MEA Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 367 MEA Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 368 MEA Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 369 MEA Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 370 MEA Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 371 MEA Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 372 MEA Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 373 MEA Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 374 MEA Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 375 MEA Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 376 MEA Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 377 MEA Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 378 MEA Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 379 MEA Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 380 MEA Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 381 MEA Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 382 MEA Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 383 MEA Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 384 MEA Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 385 MEA Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 386 MEA Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 387 GCC Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 388 GCC Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 389 GCC Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 390 GCC Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 391 GCC Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 392 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 393 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 394 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 395 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 396 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 397 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 398 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 399 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 400 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 401 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 402 Abbott Laboratories: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 403 Abbott Laboratories: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 404 Abbott Laboratories: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 405 Abbott Laboratories: Net Income, 2016-2020 (US$ million, AGR%)
Figure 406 Abbott Laboratories: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 407 F.Hoffmann-La Roche Ltd.: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 408 F.Hoffmann-La Roche Ltd.: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 409 F.Hoffmann-La Roche Ltd.: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 410 F.Hoffmann-La Roche Ltd.: Net Income, 2016-2020 (US$ million, AGR%)
Figure 411 F.Hoffmann-La Roche Ltd.: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 412 GlaxoSmithKline Plc.: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 413 GlaxoSmithKline Plc.: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 414 GlaxoSmithKline Plc.: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 415 GlaxoSmithKline Plc.: Net Income, 2016-2020 (US$ million, AGR%)
Figure 416 GlaxoSmithKline Plc.: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 417 Merck & Co. Inc.: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 418 Merck & Co. Inc.: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 419 Merck & Co. Inc.: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 420 Merck & Co. Inc.: Net Income, 2016-2020 (US$ million, AGR%)
Figure 421 Merck & Co. Inc.: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 422 Viatris: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 423 Viatris: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 424 Viatris: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 425 Viatris: Net Income, 2016-2020 (US$ million, AGR%)
Figure 426 Viatris: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 427 Novartis International AG: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 428 Novartis International AG: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 429 Novartis International AG: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 430 Novartis International AG: Net Income, 2016-2020 (US$ million, AGR%)
Figure 431 Novartis International AG: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 432 Pfizer Inc: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 433 Pfizer Inc: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 434 Pfizer Inc: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 435 Pfizer Inc: Net Income, 2016-2020 (US$ million, AGR%)
Figure 436 Pfizer Inc: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 437 Sanofi: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 438 Sanofi: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 439 Sanofi: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 440 Sanofi: Net Income, 2016-2020 (US$ million, AGR%)
Figure 441 Sanofi: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 442 Teva Pharmaceutical Industries Ltd: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 443 Teva Pharmaceutical Industries Ltd: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 444 Teva Pharmaceutical Industries Ltd: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 445 Teva Pharmaceutical Industries Ltd: Net Income, 2016-2020 (US$ million, AGR%)
Figure 446 Teva Pharmaceutical Industries Ltd: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 447 Cipla Ltd: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 448 Cipla Ltd: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 449 Allergan (AbbVie Inc.): Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 450 Allergan (AbbVie Inc.): R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 451 Allergan (AbbVie Inc.): Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 452 Allergan (AbbVie Inc.): Net Income, 2016-2020 (US$ million, AGR%)
Figure 453 Allergan (AbbVie Inc.): EBDITA, 2016-2020 (US$ million, AGR%)
Figure 454 Cumberland Pharmaceuticals, Inc: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 455 Cumberland Pharmaceuticals, Inc: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 456 Cumberland Pharmaceuticals, Inc: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 457 Cumberland Pharmaceuticals, Inc: Net Income, 2016-2020 (US$ million, AGR%)
Figure 458 Cumberland Pharmaceuticals, Inc: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 459 LUPIN: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 460 Amneal Pharmaceuticals LLC: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 461 Amneal Pharmaceuticals LLC: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 462 Amneal Pharmaceuticals LLC: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 463 WOCKHARDT: Net Revenue, 2015-2020 (US$ million, AGR%)
1.1 Introduction to Antibiotics Market
1.2 Antibiotics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Market Drivers
3.1.1 Growing Burden of Infectious Diseases to Fuel Market Growth
3.1.2 Adoption of Digital Health Technology to Boost Antibiotics Market Growth
3.1.3 Rising Ageing Population Patient Pool to Drive Growth
3.2 Market Restraints
3.2.1 Strict Regulatory Scenarios to Hamper Market Growth
3.2.2 Rising Antibiotic Resistance to Restrain Market Growth
3.3 Market Opportunities
3.4 SWOT Analysis
3.4.1 Strengths of Antibiotics Market
3.4.2 Weaknesses of Antibiotics Market
3.4.3 Opportunities in Antibiotics Market
3.4.4 Threats in Antibiotics Market
3.5 Industry analysis - Porter’s
3.5.1 Bargaining Power of Buyers (Low)
3.5.2 Bargaining Power of Suppliers (Low)
3.5.3 Intensity of Competitive Rivalry (High)
3.5.4 Threat of Substitute (Low)
3.5.5 Threat of New Entrants (Low)
3.6 Industry analysis – PEST Analysis
3.6.1 Political Factors Impacting Antibiotics Market
3.6.2 Economic Factors Impacting Antibiotics Market
3.6.3 Social Factors Impacting Antibiotics Market
3.6.4 Technological Factors Impacting Antibiotics Market
4 Global Antibiotics Market by Drug Class
4.1 Cephalosporin Segment Market Forecast, 2021-2031
4.1.1 Rising Prevalence of Infectious Diseases to Fuel Segmental Growth
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Penicillin Segment Market Forecast, 2021-2031
4.2.1 Penicillin Accounts for Majority of the Antibiotics Market Share
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 Fluoroquinolone Segment Market Forecast, 2021-2031
4.3.1 Fluoroquinolone Segment Anticipated to Witness Highest Growth Over the Forecast Period
4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.4 Macrolide Segment Market Forecast, 2021-2031
4.4.1 Rising Demand of Drugs for Bacterial Skin Infections to Fuel Growth
4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.5 Carbapenem Segment Market Forecast, 2021-2031
4.5.1 Market Overview
4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.6 Aminoglycoside Segment Market Forecast, 2021-2031
4.6.1 Market Overview
4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.7 Sulfonamide Segment Market Forecast, 2021-2031
4.7.1 Market Overview
4.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.8 7-ACA Segment Market Forecast, 2021-2031
4.8.1 Market Overview
4.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.9 Others Segment Market Forecast, 2021-2031
4.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Antibiotics Market by Action Mechanism
5.1 Cell Wall Synthesis Inhibitors Segment Market Forecast, 2021-2031
5.1.1 Cell Wall Synthesis Inhibitors Accounts for Majority of the Market Share
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Protein Synthesis Inhibitors Segment Market Forecast, 2021-2031
5.2.1 R&D Initiatives Projected to Boost Protein Synthesis Inhibitors Growth
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 DNA Synthesis Inhibitors Segment Market Forecast, 2021-2031
5.3.1 Market Overview
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 RNA Synthesis Inhibitors Segment Market Forecast, 2021-2031
5.4.1 RNA Synthesis Inhibitors Anticipated to Witness Fastest CAGR Through 2031
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.5 Mycolic Acid Inhibitors Segment Market Forecast, 2021-2031
5.5.1 Market Overview
5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.6 Others Segment Market Forecast, 2021-2031
5.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Antibiotics Market by Gender
6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Antibiotics Market by Age Group
7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 Antibiotics Market by Route of Administration
8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 North America Antibiotics Market
9.1 North America Dominates the Global Antibiotics Market
9.2 North America Antibiotics Market by Country, Forecast 2021-2031
9.3 North America Antibiotics Market by Action Mechanism, Forecast 2021-2031
9.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Action Mechanism Forecast, 2021-2031
9.4 North America Antibiotics Market by Drug Class, Forecast 2021-2031
9.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Drug Class Forecast, 2021-2031
9.5 North America Antibiotics Market by Gender, Forecast 2021-2031
9.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Gender Forecast, 2021-2031
9.6 North America Antibiotics Market by Age Group, Forecast 2021-2031
9.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Age Group Forecast, 2021-2031
9.7 North America Antibiotics Market by Route of Administration, Forecast 2021-2031
9.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Antibiotics Market by Route of Administration Forecast, 2021-2031
9.8 U.S. Antibiotics Market, Forecast 2021-2031
9.8.1 U.S. Currently Dominates the North American Antibiotics Market
9.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Antibiotics Market Forecast, 2021-2031
9.9 Canada Antibiotics Market, Forecast 2021-2031
9.9.1 Canadian Antibiotics Market to Witness Highest Growth Rate Across North American Region
9.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Antibiotics Market Forecast, 2021-2031
10 Europe Antibiotics Market
10.1 Growing Health Awareness to Fuel European Antibiotics Market Through 2031
10.2 Consumption of Antibactetrials in Community Across European Countries by ATC Group
10.3 Consumption of Antibactetrials in Hospital Sector Across European Countries by ATC Group
10.4 DDDs Per 1000 Inhabitants Per Day
10.5 Market Authorization & Reimbursements in Norway
10.6 Top 10 Potential Companies Outside Nordic Region
10.7 Regulatory Scenario Across Europe
10.8 Europe Antibiotics Market by Country, Forecast 2021-2031
10.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Country Forecast, 2021-2031
10.9 Europe Antibiotics Market by Action Mechanism, Forecast 2021-2031
10.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Action Mechanism Forecast, 2021-2031
10.10 Europe Antibiotics Market by Drug Class, Forecast 2021-2031
10.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Drug Class Forecast, 2021-2031
10.11 Europe Antibiotics Market by Gender, Forecast 2021-2031
10.11.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Gender Forecast, 2021-2031
10.12 Europe Antibiotics Market by Age Group, Forecast 2021-2031
10.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Age Group Forecast, 2021-2031
10.13 Europe Antibiotics Market by Route of Administration, Forecast 2021-2031
10.13.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Antibiotics Market by Route of Administration Forecast, 2021-2031
10.14 Germany Antibiotics Market, Forecast 2021-2031
10.14.1 German Antibiotics Market to Witness Highest Growth Rate by 2031
10.14.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Antibiotics Market Forecast, 2021-2031
10.15 UK Antibiotics Market, Forecast 2021-2031
10.15.1 Collaboration Among Healthcare Organizations to Fuel Regional Antibiotics Market Growth
10.15.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Antibiotics Market Forecast, 2021-2031
10.16 France Antibiotics Market, Forecast 2021-2031
10.16.1 Rising Incidence of Infectious Diseases to Augur French Antibiotics Market Growth
10.16.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Antibiotics Market Forecast, 2021-2031
10.17 Italy Antibiotics Market, Forecast 2021-2031
10.17.1 High Awareness Regarding Usage of Antibiotics is Anticipated to Boost Italian Antibiotics Market
10.17.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Antibiotics Market Forecast, 2021-2031
10.18 Spain Antibiotics Market, Forecast 2021-2031
10.18.1 Incidence of Influenza to Boost Regional Market Growth
10.18.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Antibiotics Market Forecast, 2021-2031
10.19 Russia Antibiotics Market, Forecast 2021-2031
10.19.1 Awareness Regarding Health Issues Anticipated to Boost Antibiotics Market Growth Through 2031
10.19.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Antibiotics Market Forecast, 2021-2031
10.20 Denmark Antibiotics Market, Forecast 2021-2031
10.20.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Denmark Antibiotics Market Forecast, 2021-2031
10.21 Norway Antibiotics Market, Forecast 2021-2031
10.21.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Norway Antibiotics Market Forecast, 2021-2031
10.22 Sweden Antibiotics Market, Forecast 2021-2031
10.22.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Sweden Antibiotics Market Forecast, 2021-2031
10.23 Finland Antibiotics Market, Forecast 2021-2031
10.23.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Finland Antibiotics Market Forecast, 2021-2031
10.24 Netherlands Antibiotics Market, Forecast 2021-2031
10.24.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Netherlands Antibiotics Market Forecast, 2021-2031
10.25 Rest of Europe Antibiotics Market, Forecast 2021-2031
10.26 Market Revenue, 2021-2031
10.26.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Antibiotics Market Forecast, 2021-2031
11 Asia Pacific Antibiotics Market
11.1 Asia Pacific Antibiotics Market to Witness Highest Growth Rate Through 2031
11.2 Asia Pacific Antibiotics Market by Country, Forecast 2021-2031
11.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Country Forecast, 2021-2031
11.3 Asia Pacific Antibiotics Market by Action Mechanism, Forecast 2021-2031
11.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Action Mechanism Forecast, 2021-2031
11.4 Asia Pacific Antibiotics Market by Drug Class, Forecast 2021-2031
11.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Drug Class Forecast, 2021-2031
11.5 Asia Pacific Antibiotics Market by Gender, Forecast 2021-2031
11.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Gender Forecast, 2021-2031
11.6 Asia Pacific Antibiotics Market by Age Group, Forecast 2021-2031
11.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Age Group Forecast, 2021-2031
11.7 Asia Pacific Antibiotics Market by Route of Administration, Forecast 2021-2031
11.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Antibiotics Market by Route of Administration Forecast, 2021-2031
11.8 China Antibiotics Market, Forecast 2021-2031
11.8.1 China Currently Dominating the APAC Antibiotics Market
11.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Antibiotics Market Forecast, 2021-2031
11.9 Japan Antibiotics Market, Forecast 2021-2031
11.9.1 Growing Burden of Infectious Diseases to Fuel Japanese Antibiotics Market
11.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Antibiotics Market Forecast, 2021-2031
11.10 India Antibiotics Market, Forecast 2021-2031
11.10.1 Indian Antibiotics Market to Witness Highest Growth Rate Through 2031
11.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Antibiotics Market Forecast, 2021-2031
11.11 Australia Antibiotics Market, Forecast 2021-2031
11.11.1 Australian Antibiotics Market to Offer Significant Growth Opportunities
11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Antibiotics Market Forecast, 2021-2031
11.12 Singapore Antibiotics Market, Forecast 2021-2031
11.12.1 Singapore Antibiotics Market to Grow on Account of Rising Incidence of Infectious Diseases
11.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Singapore Antibiotics Market Forecast, 2021-2031
11.13 Malaysia Antibiotics Market, Forecast 2021-2031
11.13.1 Growing Healthcare Infrastructure to Augur Antibiotics Market Growth
11.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Malaysia Antibiotics Market Forecast, 2021-2031
11.14 Sri Lanka Antibiotics Market, Forecast 2021-2031
11.14.1 Sri Lankan Antibiotics Market to Witness Significant Growth Through 2031
11.14.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Sri Lanka Antibiotics Market Forecast, 2021-2031
11.15 Rest of Asia Pacific Antibiotics Market, Forecast 2021-2031
11.15.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031
12 Latin America Antibiotics Market
12.1 Rising Healthcare Expenditure to Fuel Latin American Antibiotics Market Growth Through 2031
12.2 Latin America Antibiotics Market by Country, Forecast 2021-2031
12.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Country Forecast, 2021-2031
12.3 Latin America Antibiotics Market by Action Mechanism, Forecast 2021-2031
12.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Action Mechanism Forecast, 2021-2031
12.4 Latin America Antibiotics Market by Drug Class, Forecast 2021-2031
12.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Drug Class Forecast, 2021-2031
12.5 Latin America Antibiotics Market by Gender, Forecast 2021-2031
12.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Gender Forecast, 2021-2031
12.6 Latin America Antibiotics Market by Age Group, Forecast 2021-2031
12.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Age Group Forecast, 2021-2031
12.7 Latin America Antibiotics Market by Route of Administration, Forecast 2021-2031
12.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Antibiotics Market by Route of Administration Forecast, 2021-2031
12.8 Brazil Antibiotics Market, Forecast 2021-2031
12.8.1 Brazil Currently Dominates the Latin American Antibiotics Market
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Antibiotics Market Forecast, 2021-2031
12.9 Mexico Antibiotics Market, Forecast 2021-2031
12.9.1 Mexico to Witness Highest Growth Rate Through 2031
12.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Antibiotics Market Forecast, 2021-2031
12.10 Argentina Antibiotics Market, Forecast 2021-2031
12.10.1 Argentina Antibiotics Market to Offer Significant Growth Prospects
12.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Argentina Antibiotics Market Forecast, 2021-2031
12.11 Colombia Antibiotics Market, Forecast 2021-2031
12.11.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Colombia Antibiotics Market Forecast, 2021-2031
12.12 Rest of Latin America Antibiotics Market, Forecast 2021-2031
12.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Antibiotics Market Forecast, 2021-2031
13 MEA Antibiotics Market
13.1 Growing Awareness to Boost Demand of Antibiotics Across MEA Region
13.2 MEA Antibiotics Market by Country, Forecast 2021-2031
13.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Country Forecast, 2021-2031
13.3 MEA Antibiotics Market by Action Mechanism, Forecast 2021-2031
13.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Action Mechanism Forecast, 2021-2031
13.4 MEA Antibiotics Market by Drug Class, Forecast 2021-2031
13.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Drug Class Forecast, 2021-2031
13.5 MEA Antibiotics Market by Gender, Forecast 2021-2031
13.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Gender Forecast, 2021-2031
13.6 MEA Antibiotics Market by Age Group, Forecast 2021-2031
13.6.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Age Group Forecast, 2021-2031
13.7 MEA Antibiotics Market by Route of Administration, Forecast 2021-2031
13.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Antibiotics Market by Route of Administration Forecast, 2021-2031
13.8 GCC Antibiotics Market, Forecast 2021-2031
13.8.1 Lack of Awareness towards Antibiotics Usage to Restrain Market Growth Through 2031
13.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Antibiotics Market Forecast, 2021-2031
13.9 South Africa Antibiotics Market, Forecast 2021-2031
13.9.1 South Africa Antibiotics Market to Witness Highest Growth Rate Across MEA Region
13.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Antibiotics Market Forecast, 2021-2031
13.10 Rest of MEA Antibiotics Market, Forecast 2021-2031
13.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of MEA Antibiotics Market Forecast, 2021-2031
14 Company Profiles
14.1 Antibiotics Market: Company Wise Ranking
14.2 Key Strategies Followed by Leading Antibiotics Players
14.2.1 Internationalization
14.2.2 Product Range Breadth
14.2.3 Capability Development
14.2.4 Cost Differentiation
14.2.5 Vertical Integration
14.3 Abbott Laboratories
14.3.1 Company Snapshot
14.3.2 Abbott Laboratories Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.4 F. Hoffmann-La Roche Ltd.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 GlaxoSmithKline Plc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.6 Merck & Co. Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Viatris (Mylan)
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.8 Novartis International AG
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Product Benchmarking
14.8.5 Recent Developments
14.9 Pfizer Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.10 Sanofi
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.4 Product Benchmarking
14.10.5 Recent Developments
14.11 Teva Pharmaceutical Industries Ltd.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
14.11.5 Recent Developments
14.12 Cipla Ltd.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 Allergan (AbbVie Inc.)
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.4 Product Benchmarking
14.13.5 Recent Developments
14.14 Cumberland Pharmaceuticals, Inc
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.4 Product Benchmarking
14.14.5 Recent Developments
14.15 LUPIN
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.4 Product Benchmarking
14.15.5 Recent Developments
14.16 Melinta Therapeutics LLC
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Product Benchmarking
14.16.4 Recent Developments
14.17 Amneal Pharmaceuticals LLC
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Product Benchmarking
14.17.5 Recent Developments
14.18 WOCKHARDT
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.4 Product Benchmarking
14.18.5 Recent Developments
15 Conclusion
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Global Antibiotics Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Antibiotics Market Forecast for Cephalosporin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Antibiotics Market Forecast for Penicillin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Antibiotics Market Forecast for Fluroquinolone Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 19 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 20 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 21 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 22 Antibiotics Market Forecast for Macrolide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 23 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 24 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Antibiotics Market Forecast for Carbapenem Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 29 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Antibiotics Market Forecast for Aminoglycoside Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 34 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 35 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 36 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 37 Antibiotics Market Forecast for Sulfonamide Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 38 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 39 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 40 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 41 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 42 Antibiotics Market Forecast for 7-ACA Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 43 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 44 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 45 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 46 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 47 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 48 Global Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 49 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Antibiotics Market Forecast for Cell Wall Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 55 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Antibiotics Market Forecast for Protein Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 60 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 61 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 62 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 63 Antibiotics Market Forecast for DNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 64 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 65 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 66 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 67 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 68 Antibiotics Market Forecast for RNA Synthesis Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 69 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 70 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 71 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 72 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 73 Antibiotics Market Forecast for Mycolic Acid Inhibitors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 74 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 75 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 76 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 77 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 78 Antibiotics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 79 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 80 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 Global Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 85 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 86 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 87 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 88 Global Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 89 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 90 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 91 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 92 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 93 Global Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 94 North America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 95 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 96 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 97 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 98 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 99 North America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 100 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 101 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 102 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 103 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 104 North America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 105 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 106 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 107 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 108 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 109 North America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 110 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 111 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 112 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 113 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 114 North America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 115 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 116 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 117 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 118 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 119 North America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 120 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 121 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 122 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 123 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 124 U.S. Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 125 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 126 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 127 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 128 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 129 Canada Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 130 Consumption of antibacterial for systemic use (ATC group J01) in the community, by country and ATC group level 3, EU/EEA, 2019 (expressed as DDD per 1 000 inhabitants per day)
Table 131 Consumption of antibacterials for systemic use (ATC group J01) in the Hospital Sector, by country and ATC group level 3, EU/EEA, 2019 (expressed as DDD per 1 000 inhabitants per day)
Table 132 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 133 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Europe Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 138 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Europe Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 143 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Europe Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 148 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Europe Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 153 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 154 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 155 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 156 Europe Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 157 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 158 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 159 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 160 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 161 Europe Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 162 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 163 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 164 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 165 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 166 Germany Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 167 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 168 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 169 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 170 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 171 UK Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 172 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 173 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 174 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 175 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 176 France Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 177 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 178 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 179 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 180 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 181 Italy Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 182 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 183 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 184 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 185 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 186 Spain Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 187 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 188 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 189 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 190 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 191 Russia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 192 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 193 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 194 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 195 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 196 Denmark Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 197 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 198 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 199 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 200 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 201 Norway Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 202 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 203 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 Sweden Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 208 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 Finland Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 213 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 218 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 223 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 224 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 225 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 226 APAC Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 227 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 228 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 229 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 230 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 231 APAC Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 232 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 233 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 234 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 235 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 236 APAC Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 237 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 238 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 239 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 240 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 241 APAC Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 242 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 243 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 244 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 245 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 246 APAC Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 247 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 248 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 249 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 250 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 251 APAC Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 252 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 253 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 254 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 255 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 256 China Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 257 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 258 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 259 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 260 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 261 Japan Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 262 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 263 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 264 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 265 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 266 India Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 267 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 268 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 269 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 270 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 271 Australia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 272 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 273 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 274 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 275 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 276 Singapore Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 277 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 278 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 279 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 280 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 281 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 282 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 283 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 284 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 285 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 286 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 287 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 288 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 289 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 290 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 291 Rest of APAC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 292 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 293 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 294 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 295 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 296 Latin America Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 297 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 298 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 299 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 300 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 301 Latin America Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 302 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 303 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 304 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 305 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 306 Latin America Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 307 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 308 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 309 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 310 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 311 Latin America Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 312 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 313 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 314 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 315 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 316 Latin America Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 317 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 318 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 319 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 320 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 321 Latin America Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 322 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 323 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 324 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 325 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 326 Brazil Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 327 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 328 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 329 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 330 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 331 Mexico Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 332 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 333 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 334 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 335 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 336 Argentina Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 337 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 338 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 339 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 340 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 341 Colombia Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 342 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 343 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 344 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 345 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 346 Rest of LATAM Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 347 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 348 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 349 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 350 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 351 MEA Antibiotics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 352 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 353 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 354 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 355 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 356 MEA Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 357 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 358 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 359 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 360 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 361 MEA Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 362 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 363 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 364 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 365 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 366 MEA Antibiotics Market Forecast by Gender, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 367 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 368 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 369 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 370 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 371 MEA Antibiotics Market Forecast by Age Group, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 372 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 373 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 374 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 375 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 376 MEA Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 377 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 378 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 379 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 380 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 381 GCC Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 382 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 383 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 384 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 385 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 386 South Africa Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 387 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 388 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 389 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 390 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 391 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 392 Global Antibiotics Market: Company Ranking
Table 393 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 394 Abbott Laboratories: Product Benchmarking
Table 395 Abbott.: Recent Developments till 2021
Table 396 F.Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 397 F.Hoffmann-La Roche Ltd.: Product Benchmarking
Table 398 F.Hoffmann-La Roche Ltd.: Recent Developments till 2021
Table 399 GlaxoSmithKline Plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 400 GlaxoSmithKline Plc.: Product Benchmarking
Table 401 GlaxoSmithKline Plc.: Recent Developments till 2021
Table 402 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 403 Merck & Co. Inc.: Product Benchmarking
Table 404 Merck & Co. Inc.: Recent Developments till 2021
Table 405 Viatris: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 406 Viatris: Product Benchmarking
Table 407 Viatris: Recent Developments till 2021
Table 408 Novartis International AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 409 Novartis International AG: Product Benchmarking
Table 410 Novartis International AG: Recent Developments till 2021
Table 411 Pfizer Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 412 Pfizer Inc: Product Benchmarking
Table 413 Pfizer Inc: Recent Developments till 2021
Table 414 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 415 Sanofi: Product Benchmarking
Table 416 Sanofi.: Recent Developments till 2021
Table 417 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 418 Teva Pharmaceutical Industries Ltd: Product Benchmarking
Table 419 Teva Pharmaceutical Industries Ltd .: Recent Developments till 2021
Table 420 Cipla Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 421 Cipla Ltd: Product Benchmarking
Table 422 Cipla Ltd: Recent Developments till 2021
Table 423 Allergan (AbbVie Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 424 Allergan (AbbVie Inc.): Product Benchmarking
Table 425 Allergan (AbbVie Inc.): Recent Developments till 2021
Table 426 Cumberland Pharmaceuticals, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 427 Cumberland Pharmaceuticals, Inc: Product Benchmarking
Table 428 Cumberland Pharmaceuticals, Inc: Recent Developments, 2017-2019
Table 429 LUPIN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 430 LUPIN: Product Benchmarking
Table 431 LUPIN: Recent Developments till 2021
Table 432 Melinta Therapeutics LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 433 Melinta Therapeutics LLC: Product Benchmarking
Table 434 Melinta Therapeutics LLC: Recent Developments till 2021
Table 435 Amneal Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 436 Amneal Pharmaceuticals LLC: Product Benchmarking
Table 437 Amneal Pharmaceuticals LLC: Recent Developments, 2017-2019
Table 438 WOCKHARDT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 439 WOCKHARDT: Product Benchmarking
Table 440 WOCKHARDT: Recent Developments till 2021
List of Figures
Figure 1 Global Antibiotics Market Segmentation
Figure 2 Antibiotics Market: Market Trends
Figure 3 Antibiotics Market: SWOT Analysis
Figure 4 Porter’s Analysis
Figure 5 PEST Analysis
Figure 6 Antibiotics Market Forecast by Drug Class, 2021-2031 (US$ million, AGR %)
Figure 7 Antibiotics Market Share Forecast by Drug Class, 2021, 2026, 2031 (%)
Figure 8 Antibiotics Market for Cephalosporin Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 9 Antibiotics Market for Cephalosporin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 10 Antibiotics Market for Cephalosporin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 11 Antibiotics Market for Cephalosporin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 12 Antibiotics Market for Cephalosporin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 13 Antibiotics Market for Penicillin Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 14 Antibiotics Market for Penicillin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 15 Antibiotics Market for Penicillin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 16 Antibiotics Market for Penicillin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 17 Antibiotics Market for Penicillin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 18 Antibiotics Market for Fluoroquinolone Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 19 Antibiotics Market for Fluoroquinolone Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 20 Antibiotics Market for Fluoroquinolone Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 21 Antibiotics Market for Fluoroquinolone Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 22 Antibiotics Market for Fluoroquinolone Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 23 Antibiotics Market for Macrolide Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 24 Antibiotics Market for Macrolide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 25 Antibiotics Market for Macrolide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 26 Antibiotics Market for Macrolide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 27 Antibiotics Market for Macrolide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 28 Antibiotics Market for Carbapenem Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 29 Antibiotics Market for Carbapenem Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 30 Antibiotics Market for Carbapenem Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 31 Antibiotics Market for Carbapenem Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 32 Antibiotics Market for Carbapenem Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 33 Antibiotics Market for Aminoglycoside Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 34 Antibiotics Market for Aminoglycoside Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 35 Antibiotics Market for Aminoglycoside Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 36 Antibiotics Market for Aminoglycoside Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 37 Antibiotics Market for Aminoglycoside Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 38 Antibiotics Market for Sulfonamide Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 39 Antibiotics Market for Sulfonamide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 40 Antibiotics Market for Sulfonamide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 41 Antibiotics Market for Sulfonamide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 42 Antibiotics Market for Sulfonamide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 43 Antibiotics Market for 7-ACA Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 44 Antibiotics Market for 7-ACA Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 45 Antibiotics Market for 7-ACA Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 46 Antibiotics Market for 7-ACA Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 47 Antibiotics Market for 7-ACA Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 48 Antibiotics Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 49 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 50 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 51 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 52 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 53 Antibiotics Market Forecast by Action Mechanism, 2021-2031 (US$ million, AGR %)
Figure 54 Antibiotics Market Share Forecast by Action Mechanism, 2021, 2026, 2031 (%)
Figure 55 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 56 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 57 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 58 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 59 Antibiotics Market for Cell Wall Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 60 Antibiotics Market for Protein Synthesis Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 61 Antibiotics Market for Protein Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 62 Antibiotics Market for Protein Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 63 Antibiotics Market for Protein Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 64 Antibiotics Market for Protein Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 65 Antibiotics Market for DNA Synthesis Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 66 Antibiotics Market for DNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 67 Antibiotics Market for DNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 68 Antibiotics Market for DNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 69 Antibiotics Market for DNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 70 Antibiotics Market for RNA Synthesis Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 71 Antibiotics Market for RNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 72 Antibiotics Market for RNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 73 Antibiotics Market for RNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 74 Antibiotics Market for RNA Synthesis Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 75 Antibiotics Market for Mycolic Acid Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 76 Antibiotics Market for Mycolic Acid Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 77 Antibiotics Market for Mycolic Acid Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 78 Antibiotics Market for Mycolic Acid Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 79 Antibiotics Market for Mycolic Acid Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 80 Antibiotics Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 81 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 Antibiotics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 Antibiotics Market Forecast by Gender, 2021-2031 (US$ million, AGR %)
Figure 86 Antibiotics Market by Gender Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 87 Antibiotics Market by Gender Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 88 Antibiotics Market by Gender Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 89 Antibiotics Market by Gender Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 90 Antibiotics Market Forecast by Age Group, 2021-2031 (US$ million, AGR %)
Figure 91 Antibiotics Market by Age Group Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 92 Antibiotics Market by Age Group Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 93 Antibiotics Market by Age Group Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 94 Antibiotics Market by Age Group Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 95 Antibiotics Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR %)
Figure 96 Antibiotics Market by Route of Administration Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 97 Antibiotics Market by Route of Administration Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 98 Antibiotics Market by Route of Administration Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 99 Antibiotics Market by Route of Administration Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 100 North America Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 101 North America Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 102 North America Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 103 North America Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 104 North America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 105 North America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 106 North America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 107 North America Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 108 North America Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 109 North America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 110 North America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 111 North America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 112 North America Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 113 North America Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 114 North America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 115 North America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 116 North America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 117 North America Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 118 North America Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 119 North America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 120 North America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 121 North America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 122 North America Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 123 North America Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 124 North America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 125 North America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 126 North America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 127 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 128 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 129 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 130 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 131 U.S. Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 132 Canada Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 133 Canada Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 134 Canada Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 135 Canada Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 136 Canada Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 137 Consumption of antibacterials for systemic use (ATC group J01) in the community, by country and ATC group level 3, EU/EEA, 2019 (expressed as DDD per 1 000 inhabitants per day)
Figure 138 Europe Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 139 Europe Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 140 Europe Antibiotics Market by Country Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 141 Europe Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 142 Europe Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 143 Europe Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 144 Europe Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 145 Europe Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 146 Europe Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 147 Europe Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 148 Europe Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 149 Europe Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 150 Europe Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 151 Europe Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 152 Europe Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 153 Europe Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 154 Europe Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 155 Europe Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 156 Europe Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 157 Europe Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 158 Europe Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 159 Europe Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 160 Europe Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 161 Europe Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 162 Europe Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 163 Europe Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 164 Europe Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 165 Europe Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 166 Europe Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 167 Europe Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 168 Europe Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 169 Germany Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 170 Germany Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 171 Germany Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 172 Germany Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 173 Germany Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 174 UK Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 175 UK Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 176 UK Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 177 UK Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 178 UK Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 179 France Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 180 France Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 181 France Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 182 France Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 183 France Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 184 Italy Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 185 Italy Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 186 Italy Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 187 Italy Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 188 Italy Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 189 Spain Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 190 Spain Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 191 Spain Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 192 Spain Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 193 Spain Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 194 Russia Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 195 Russia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 196 Russia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 197 Russia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 198 Russia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 199 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 200 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 201 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 202 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 203 Denmark Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 204 Norway Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 205 Norway Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 206 Norway Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 207 Norway Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 208 Norway Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 209 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 210 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 211 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 212 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 213 Sweden Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 214 Finland Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 215 Finland Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 216 Finland Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 217 Finland Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 218 Finland Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 219 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 220 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 221 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 222 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 223 Netherlands Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 224 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 225 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 226 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 227 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 228 Rest of Europe Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 229 Asia Pacific Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 230 Asia Pacific Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 231 Asia Pacific Antibiotics Market by Country Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 232 Asia Pacific Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 233 Asia Pacific Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 234 Asia Pacific Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 235 Asia Pacific Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 236 Asia Pacific Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 237 Asia Pacific Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 238 Asia Pacific Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 239 Asia Pacific Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 240 Asia Pacific Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 241 Asia Pacific Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 242 Asia Pacific Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 243 Asia Pacific Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 244 Asia Pacific Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 245 Asia Pacific Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 246 Asia Pacific Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 247 Asia Pacific Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 248 Asia Pacific Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 249 Asia Pacific Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 250 Asia Pacific Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 251 Asia Pacific Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 252 Asia Pacific Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 253 Asia Pacific Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 254 Asia Pacific Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 255 Asia Pacific Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 256 Asia Pacific Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 257 Asia Pacific Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 258 Asia Pacific Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 259 Asia Pacific Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 260 China Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 261 China Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 262 China Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 263 China Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 264 China Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 265 Japan Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 266 Japan Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 267 Japan Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 268 Japan Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 269 Japan Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 270 India Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 271 India Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 272 India Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 273 India Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 274 India Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 275 Australia Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 276 Australia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 277 Australia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 278 Australia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 279 Australia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 280 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 281 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 282 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 283 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 284 Singapore Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 285 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 286 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 287 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 288 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 289 Malaysia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 290 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 291 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 292 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 293 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 294 Sri Lanka Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 295 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 296 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 297 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 298 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 299 Rest of Asia Pacific Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 300 Latin America Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 301 Latin America Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 302 Latin America Antibiotics Market by Country Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 303 Latin America Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 304 Latin America Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 305 Latin America Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 306 Latin America Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 307 Latin America Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 308 Latin America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 309 Latin America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 310 Latin America Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 311 Latin America Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 312 Latin America Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 313 Latin America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 314 Latin America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 315 Latin America Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 316 Latin America Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 317 Latin America Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 318 Latin America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 319 Latin America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 320 Latin America Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 321 Latin America Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 322 Latin America Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 323 Latin America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 324 Latin America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 325 Latin America Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 326 Latin America Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 327 Latin America Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 328 Latin America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 329 Latin America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 330 Latin America Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 331 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 332 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 333 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 334 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 335 Brazil Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 336 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 337 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 338 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 339 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 340 Mexico Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 341 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 342 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 343 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 344 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 345 Argentina Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 346 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 347 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 348 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 349 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 350 Colombia Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 351 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 352 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 353 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 354 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 355 Rest of Latin America Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 356 MEA Antibiotics Market Forecast by Country 2021-2031 (US$ million)
Figure 357 MEA Antibiotics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 358 MEA Antibiotics Market by Country Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 359 MEA Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 360 MEA Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 361 MEA Antibiotics Market Country Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 362 MEA Antibiotics Market Forecast by Action Mechanism 2021-2031 (US$ million)
Figure 363 MEA Antibiotics Market by Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 364 MEA Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 365 MEA Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 366 MEA Antibiotics Market Action Mechanism Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 367 MEA Antibiotics Market Forecast by Drug Class 2021-2031 (US$ million)
Figure 368 MEA Antibiotics Market by Drug Class Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 369 MEA Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 370 MEA Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 371 MEA Antibiotics Market Drug Class Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 372 MEA Antibiotics Market Forecast by Gender 2021-2031 (US$ million)
Figure 373 MEA Antibiotics Market by Gender Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 374 MEA Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 375 MEA Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 376 MEA Antibiotics Market Gender Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 377 MEA Antibiotics Market Forecast by Age Group 2021-2031 (US$ million)
Figure 378 MEA Antibiotics Market by Age Group Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 379 MEA Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 380 MEA Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 381 MEA Antibiotics Market Age Group Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 382 MEA Antibiotics Market Forecast by Route of Administration 2021-2031 (US$ million)
Figure 383 MEA Antibiotics Market by Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 384 MEA Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 385 MEA Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 386 MEA Antibiotics Market Route of Administration Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 387 GCC Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 388 GCC Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 389 GCC Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 390 GCC Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 391 GCC Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 392 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 393 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 394 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 395 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 396 South Africa Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 397 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million)
Figure 398 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 399 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 400 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 401 Rest of MEA Antibiotics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 402 Abbott Laboratories: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 403 Abbott Laboratories: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 404 Abbott Laboratories: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 405 Abbott Laboratories: Net Income, 2016-2020 (US$ million, AGR%)
Figure 406 Abbott Laboratories: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 407 F.Hoffmann-La Roche Ltd.: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 408 F.Hoffmann-La Roche Ltd.: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 409 F.Hoffmann-La Roche Ltd.: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 410 F.Hoffmann-La Roche Ltd.: Net Income, 2016-2020 (US$ million, AGR%)
Figure 411 F.Hoffmann-La Roche Ltd.: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 412 GlaxoSmithKline Plc.: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 413 GlaxoSmithKline Plc.: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 414 GlaxoSmithKline Plc.: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 415 GlaxoSmithKline Plc.: Net Income, 2016-2020 (US$ million, AGR%)
Figure 416 GlaxoSmithKline Plc.: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 417 Merck & Co. Inc.: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 418 Merck & Co. Inc.: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 419 Merck & Co. Inc.: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 420 Merck & Co. Inc.: Net Income, 2016-2020 (US$ million, AGR%)
Figure 421 Merck & Co. Inc.: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 422 Viatris: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 423 Viatris: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 424 Viatris: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 425 Viatris: Net Income, 2016-2020 (US$ million, AGR%)
Figure 426 Viatris: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 427 Novartis International AG: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 428 Novartis International AG: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 429 Novartis International AG: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 430 Novartis International AG: Net Income, 2016-2020 (US$ million, AGR%)
Figure 431 Novartis International AG: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 432 Pfizer Inc: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 433 Pfizer Inc: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 434 Pfizer Inc: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 435 Pfizer Inc: Net Income, 2016-2020 (US$ million, AGR%)
Figure 436 Pfizer Inc: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 437 Sanofi: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 438 Sanofi: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 439 Sanofi: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 440 Sanofi: Net Income, 2016-2020 (US$ million, AGR%)
Figure 441 Sanofi: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 442 Teva Pharmaceutical Industries Ltd: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 443 Teva Pharmaceutical Industries Ltd: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 444 Teva Pharmaceutical Industries Ltd: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 445 Teva Pharmaceutical Industries Ltd: Net Income, 2016-2020 (US$ million, AGR%)
Figure 446 Teva Pharmaceutical Industries Ltd: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 447 Cipla Ltd: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 448 Cipla Ltd: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 449 Allergan (AbbVie Inc.): Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 450 Allergan (AbbVie Inc.): R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 451 Allergan (AbbVie Inc.): Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 452 Allergan (AbbVie Inc.): Net Income, 2016-2020 (US$ million, AGR%)
Figure 453 Allergan (AbbVie Inc.): EBDITA, 2016-2020 (US$ million, AGR%)
Figure 454 Cumberland Pharmaceuticals, Inc: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 455 Cumberland Pharmaceuticals, Inc: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 456 Cumberland Pharmaceuticals, Inc: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 457 Cumberland Pharmaceuticals, Inc: Net Income, 2016-2020 (US$ million, AGR%)
Figure 458 Cumberland Pharmaceuticals, Inc: EBDITA, 2016-2020 (US$ million, AGR%)
Figure 459 LUPIN: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 460 Amneal Pharmaceuticals LLC: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 461 Amneal Pharmaceuticals LLC: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 462 Amneal Pharmaceuticals LLC: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 463 WOCKHARDT: Net Revenue, 2015-2020 (US$ million, AGR%)
Companies Profiled in the Report
Abbott Laboratories
Allergan (AbbVie Inc.)
Amneal Pharmaceuticals LLC
Cipla Ltd
Cumberland Pharmaceuticals, Inc.
F.Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
GlaxoSmithKline Plc
LUPIN
Melinta Therapeutics LLC
Novartis International AG
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
Viatris (Mylan)
WOCKHARDT
List of Other Companies
Achaogen
Adenium Biotech ApS
Alaxia Pharma
Allecra Therapeutics
AstraZeneca PLC
Bayer AG
Biocidium Biopharmaceuticals
BioVersys AG
Bugworks
Cadila Healthcare
Cellceutix Corporation
Cempra
ContraFect
DAIICHI SANKYO COMPANY, LIMITED
DebioPharm
Dr. Reddy's Laboratories
Eli Lilly and Company
Evotec Pharmaceuticals
EYDO Pharma
Galapagos
Johnson & Johnson Services, Inc.
Kyorin Pharmaceutical
Macleod Pharmaceuticals
Meiji Seika Pharma
MerLion Pharmaceuticals
MGB-Biopharma
MicuRx Pharmaceuticals
Nabriva Therapeutics
Nektar Therapeutics
Northern Antibiotics
Ostuka
Paratek Pharmaceuticals
Phico Therapeutics
Redx Pharma
Savara Pharmaceuticals
SHIONOGI Co., Ltd.
Summit Therapeutics
The Medicines Company
Theravance Biopharma
Torrent Pharmaceuticals
TTY Biopharma
Unichem Laboratories
Zydus Pharmaceuticals, Inc.
List of Organizations Mentioned in the Report
Alliance for the Prudent Use of Antibiotics
American Medical Association
Antibiotic Research UK
BEAM (Biotech companies in Europe combating Anti-Microbial Resistance) Alliance
Centers for Disease Control and Prevention
European Centre for Disease Prevention and Control (ECDC)
European Medicines Agency (EMA)
Food and Drug Administration (FDA)
Global Antibiotic Research & Development Partnership (GARDP)
Global Antimicrobial Resistance Surveillance System (GLASS)
Infectious Diseases Society of America
International Society of Antimicrobial Chemotherapy
Journal of Medical Society
Microbiology Society
National Institute for Health and Clinical Excellence (NICE)
National Institutes of Health (NIH)
Society of Hospital Medicine
The British Society for Antimicrobial Chemotherapy (BSAC)
The Infectious Diseases Society of America (IDSA)
World Health Organization (WHO)
Abbott Laboratories
Allergan (AbbVie Inc.)
Amneal Pharmaceuticals LLC
Cipla Ltd
Cumberland Pharmaceuticals, Inc.
F.Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
GlaxoSmithKline Plc
LUPIN
Melinta Therapeutics LLC
Novartis International AG
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
Viatris (Mylan)
WOCKHARDT
List of Other Companies
Achaogen
Adenium Biotech ApS
Alaxia Pharma
Allecra Therapeutics
AstraZeneca PLC
Bayer AG
Biocidium Biopharmaceuticals
BioVersys AG
Bugworks
Cadila Healthcare
Cellceutix Corporation
Cempra
ContraFect
DAIICHI SANKYO COMPANY, LIMITED
DebioPharm
Dr. Reddy's Laboratories
Eli Lilly and Company
Evotec Pharmaceuticals
EYDO Pharma
Galapagos
Johnson & Johnson Services, Inc.
Kyorin Pharmaceutical
Macleod Pharmaceuticals
Meiji Seika Pharma
MerLion Pharmaceuticals
MGB-Biopharma
MicuRx Pharmaceuticals
Nabriva Therapeutics
Nektar Therapeutics
Northern Antibiotics
Ostuka
Paratek Pharmaceuticals
Phico Therapeutics
Redx Pharma
Savara Pharmaceuticals
SHIONOGI Co., Ltd.
Summit Therapeutics
The Medicines Company
Theravance Biopharma
Torrent Pharmaceuticals
TTY Biopharma
Unichem Laboratories
Zydus Pharmaceuticals, Inc.
List of Organizations Mentioned in the Report
Alliance for the Prudent Use of Antibiotics
American Medical Association
Antibiotic Research UK
BEAM (Biotech companies in Europe combating Anti-Microbial Resistance) Alliance
Centers for Disease Control and Prevention
European Centre for Disease Prevention and Control (ECDC)
European Medicines Agency (EMA)
Food and Drug Administration (FDA)
Global Antibiotic Research & Development Partnership (GARDP)
Global Antimicrobial Resistance Surveillance System (GLASS)
Infectious Diseases Society of America
International Society of Antimicrobial Chemotherapy
Journal of Medical Society
Microbiology Society
National Institute for Health and Clinical Excellence (NICE)
National Institutes of Health (NIH)
Society of Hospital Medicine
The British Society for Antimicrobial Chemotherapy (BSAC)
The Infectious Diseases Society of America (IDSA)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Antibiotics Market Report 2021-2031Related reports
-
Anti-Infective Agents Market Report 2021-2031
Rising incidences of infectious diseases is one of the prime factors driving the growth of the global anti-infective agents market...Full DetailsPublished: 11 May 2021 -
Digital Clinical Supply Chain Market Report 2020-2030
Our 430+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry...
Full DetailsPublished: 04 April 2021 -
Cancer Diagnostics Market Report 2021-2031
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel...Full DetailsPublished: 14 April 2021 -
Global Clinical Trial Management System Market Forecast 2020-2030
The global market for clinical trial management systems was valued to be $1,152m in 2019 and is valued to reach...
Full DetailsPublished: 17 March 2020 -
Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power,...Full DetailsPublished: 31 March 2021 -
Cell Therapy Technologies Market Report 2021-2031
Cell therapy technology is one of the fastest growing markets and is an ever-changing landscape. It represents the umbrella of...Full DetailsPublished: 10 March 2021 -
Therapeutic Respiratory Devices Market Report 2021-2031
The worldwide demand for therapeutic respiratory devices market is anticipated to grow on account of rising burden of respiratory diseases,...Full DetailsPublished: 26 April 2021 -
Enteric Soft Gel Capsules Market Report 2021-2031
Where the Enteric Soft Gel Capsules is market heading? If you are involved in this sector you must read this...Full DetailsPublished: 01 January 1970 -
Cell-Based Assays Market Report to 2030
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are...Full DetailsPublished: 04 March 2021 -
Antisense Oligonucleotide (ASO) Therapeutics Market Report 2021-2031
Over the last few years, the antisense oligonucleotide therapeutics has gained widespread attention due to the technological advancements and growth...Full DetailsPublished: 17 March 2021
Download sample pages
Complete the form below to download your free sample pages for Antibiotics Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
